| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026596 |
| Receipt No. | R000030539 |
| Official scientific title of the study | A study of efficacy of plant-derived product in female with voiding dysfunction. |
| Date of disclosure of the study information | 2019/02/28 |
| Last modified on | 2017/11/30 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A study of efficacy of plant-derived product in female with voiding dysfunction. | |
| Title of the study (Brief title) | A study of efficacy of plant-derived product in female with voiding dysfunction. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of plant-derived product in female with voiding dysfunction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Bladder diary |
| Key secondary outcomes | OABSS,N-QOL,PSQI-j |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | plant-derived product 28g per day for 8 weeks | |
| Interventions/Control_2 | placebo-controlled food 28g per day for 8 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Females who are age from 20 to 80. | |||
| Key exclusion criteria | 1) LUTS/OAB patients or subjects who need to treatment of disease.
2) Subjects who have the habit of taking test food. 3) Subjects who have the habit of taking healthcare products. 4) Subjects who have a habit of binge drinking. 5) Patients who have serious disease or subjects who have serious disease history. 6) Subjects who take warfarin potassium or antacid. 7) Subjects who has allergies to plants. 8) Urinary calculus or bladder calculus. 9) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. 10) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 11) Subjects who are participated in other clinical studies. 12) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. 13) Subjects who are judged unfit to enroll in this trial by the investigator. |
|||
| Target sample size | 84 | |||
| Research contact person | |
| Name of lead principal investigator | Kenji Matsu |
| Organization | Marukai Corporation |
| Division name | None |
| Address | 18-5, 1-chome, Kyomachibori, Nishi-ku, OSAKA, 550-0003 JAPAN |
| TEL | 06-6443-0073 |
| kenji_matsu@marukai.co.jp | |
| Public contact | |
| Name of contact person | Hiroko Kageyama |
| Organization | Marukai Corporation |
| Division name | Sale dept. |
| Address | 18-5, 1-chome, Kyomachibori, Nishi-ku, OSAKA, 550-0003 JAPAN |
| TEL | 06-6443-0073 |
| Homepage URL | |
| hiroko_kageyama@marukai.co.jp | |
| Sponsor | |
| Institute | TTC Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030539 |